Search - tctmd.com

Displaying 161 - 180 of 233

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Once the Cycle of Low-Risk Studies is Completed, Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis

Presenter: Allan Schwartz, Stephan Windecker, Michael J. Reardon

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk

Presenter: Lars Sondergaard

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

UK All-Comers

Presenter: Neil E. Moat

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Evolut R Low-Risk

Presenter: Jeffrey J. Popma

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Partner 3 Low-Risk

Presenter: Martin B. Leon

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

TAVR Case Selection in the Real World: Based on Society Guidelines OR Risk Models OR Clinical and Anatomic Factors?

Presenter: Allan Schwartz, Stephan Windecker, Neil E. Moat

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

TAVR Outcomes for Bicuspid Aortic Valve Disease in Asian Patients

Presenter: John C Laschinger, Mathew Williams, Jung-Min Ahn

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Instructive Case Examples: A Tale of Three Bicuspids To Treat or Not to Treat?

Presenter: John C Laschinger, Mathew Williams, Hasan Jilaihawi

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

TAVR Device Selection and CT Sizing for Bicuspid Aortic Valves

Presenter: John C Laschinger, Mathew Williams, Didier Tchetche

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

A CT Imaging Perspective of Bicuspid Aortic Valve Disease Anatomic Patterns Favorable for TAVR

Presenter: John C Laschinger, Mathew Williams, Jonathon A. Leipsic

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

A Surgeons Perspective of Bicuspid Aortic Valve Disease Anatomic Patterns Favorable for TAVR

Presenter: John C Laschinger, Mathew Williams, Michael J. Mack

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Adam B. Greenbaum

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Adnan K. Chhatriwalla

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Philipp Blanke

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #3: A Small (Undersized) Surgical Bioprosthesis

Presenter: Michael J. Reardon, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #2: A Stentless (or Stented With Leaflets Outside the Stent) Surgical Bioprosthesis

Presenter: Brian K. Whisenant, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #1: A Poorly Visible Surgical Bioprosthesis

Presenter: Isaac George, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

A Tutorial on Surgical Bioprosthesis Design: Impact on ViV Therapy

Presenter: Vinayak Bapat, Ran Kornowski

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Updates from the EVOLUT R Aortic Valve-in-Valve Registry (VIVA)

Presenter: Vinayak Bapat, Ran Kornowski

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Updates from the PARTNER Aortic Valve-in-Valve Registry

Presenter: Vinayak Bapat, Ran Kornowski, Michael J. Mack

June 21, 2018

Advertisement

Once the Cycle of Low-Risk Studies is Completed, Predicting the Role of Surgery and Surgeons in the Treatment of Aortic Stenosis

NOTION 1 - Five-Year FU and Notion 2 - Young & Low-Risk

UK All-Comers

Evolut R Low-Risk

Partner 3 Low-Risk

TAVR Case Selection in the Real World: Based on Society Guidelines OR Risk Models OR Clinical and Anatomic Factors?

TAVR Outcomes for Bicuspid Aortic Valve Disease in Asian Patients

Instructive Case Examples: A Tale of Three Bicuspids To Treat or Not to Treat?

TAVR Device Selection and CT Sizing for Bicuspid Aortic Valves

A CT Imaging Perspective of Bicuspid Aortic Valve Disease Anatomic Patterns Favorable for TAVR

A Surgeons Perspective of Bicuspid Aortic Valve Disease Anatomic Patterns Favorable for TAVR

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Case #3: A Small (Undersized) Surgical Bioprosthesis

Case #2: A Stentless (or Stented With Leaflets Outside the Stent) Surgical Bioprosthesis

Case #1: A Poorly Visible Surgical Bioprosthesis

A Tutorial on Surgical Bioprosthesis Design: Impact on ViV Therapy

Updates from the EVOLUT R Aortic Valve-in-Valve Registry (VIVA)

Updates from the PARTNER Aortic Valve-in-Valve Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content